CureZone   Log On   Join
Strattera Adverse Events: Deaths Mount - Will EU Health Authorities Intervene?
chrisb1 Views: 2,249
Published: 11 years ago

Strattera Adverse Events: Deaths Mount - Will EU Health Authorities Intervene?

Will European Health Authorities act on reports of serious side effects and deaths connected with the ADHD drug Strattera? Are 95 deaths, 965 reports of suicidal behavior and some 60,000 reported adverse events enough to take action, asks Swedish researcher Janne Larsson in a letter to the UK's Medicines Agency.

Eli Lilly's ADHD drug Strattera (atomoxetine HCl), is promoted as the first non-stimulant medication that's FDA-approved to treat ADHD in Children, adolescents, and adults. Side effects are downplayed. Tiredness and nausea are listed as common but rarely, the company says, are there suicidal thoughts in children (not adults), or liver damage.

Janne Larsen, a Swedish investigator, charges that these official pronouncements of Eli Lilly are in sharp contrast with real world deaths and frequently observed suicidal tendencies as well as episodes of psychosis, mania and aggression that keep being reported to Adverse Drug Reactions databases. A clinical trial in Sweden in 2005 turned out disastrous for the drug.............................


Printer-friendly version of this page Email this message to a friend

This Forum message belongs to a larger discussion thread. See the complete thread below. You can reply to this message!


Donate to CureZone

CureZone Newsletter is distributed in partnership with

Contact Us - Advertise - Stats

Copyright 1999 - 2019

0.266 sec, (1)